Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07451093 · ClinicalTrials.gov registry record · NA
Epileptiform Potential of Fully Immersive Virtual Reality
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07451093 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT07451093, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are: \- does use of virtual reality headsets with hand controllers result in a higher risk of seizure compared to use of virtual reality headsets without hand controllers Participants will be asked to wear a virtual reality headset during continuous video EEG recording and EEG with be evaluated during three phases: with display turned off, with display turned on without hand controllers, and with display turned on with hand controllers.
Interventions
- OTHER Virtual Reality Headset, display off
- OTHER Virtual Reality Headset, Display only
- OTHER Virtual Reality Headset, Display and Hand Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07451093
The ClinicalTrials.gov registry entry for NCT07451093 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Virtual Reality Headset, display off is the first listed.
NCT07451093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07451093 about?
NCT07451093 is a clinical study titled "Epileptiform Potential of Fully Immersive Virtual Reality". The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are: \- does use of virtual reality headsets with hand controllers result in a ...
What is the current status of trial NCT07451093?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07451093?
The interventions under investigation include: Virtual Reality Headset, display off (OTHER), Virtual Reality Headset, Display only (OTHER), Virtual Reality Headset, Display and Hand Control (OTHER).
Who is sponsoring clinical trial NCT07451093?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.